Dev

Apolipoprotein E4 as a Therapeutic Target for Alzheimer’s Disease: Identification of Small-Molecule Structure Correctors That Prevent Apolipoprotein E4 Associated Neuropathology Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

A Systematic Programme to Develop and Evaluate the Best Candidate Treatments for Repositioning as Therapies for Alzheimer s Disease (SMART-AD). Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

The molecular mechanisms of structural conversion and toxicity in amyloid disease. Investments > €500k United Kingdom Neurodegenerative disease in general 2016    

Targeting the pathological pathways to Parkinson’s Investments > €500k United Kingdom Parkinson’s disease & PD-related disorders 2016    

Tracking Parkinson’s with proteomic biomarkers Investments > €500k United Kingdom Parkinson’s disease & PD-related disorders 2016    

Understanding the pathological pathways to Parkinson’s Investments > €500k United Kingdom Parkinson’s disease & PD-related disorders 2016    

PaMIR: Parkinson MR imaging repository Investments > €500k United Kingdom Parkinson’s disease & PD-related disorders 2016    

Tracking Parkinson’s: Parkinson’s repository of biomarkers and networked datasets (PROBAND) Investments > €500k United Kingdom Parkinson’s disease & PD-related disorders 2016    

Generation of induced pluripotent stem cells from people with Parkinson’s / Modelling Parkinson’s with rat embryonic stem cells and transgenesis (extension) Investments > €500k United Kingdom Parkinson’s disease & PD-related disorders 2016    

A trial to assess the safety and efficacy of intermittent putamenal GDNF infusions administered via Convection Enhanced Delivery (CED) in Parkinson’s Investments > €500k United Kingdom Parkinson’s disease & PD-related disorders 2016